Published in Sci Rep on May 06, 2016
The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species. EMBO J (1989) 10.05
Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer (2004) 6.73
E-cadherin germline mutations in familial gastric cancer. Nature (1998) 6.72
Structural basis of cell-cell adhesion by cadherins. Nature (1995) 6.56
New signals from the invasive front. Nature (2006) 5.51
The juxtamembrane region of the cadherin cytoplasmic tail supports lateral clustering, adhesive strengthening, and interaction with p120ctn. J Cell Biol (1998) 4.38
Cadherin-catenin complex: protein interactions and their implications for cadherin function. J Cell Biochem (1996) 3.95
Balancing forces: architectural control of mechanotransduction. Nat Rev Mol Cell Biol (2011) 3.87
The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci (2008) 3.77
Cadherins as modulators of cellular phenotype. Annu Rev Cell Dev Biol (2003) 3.67
Cadherins and cancer: how does cadherin dysfunction promote tumor progression? Oncogene (2008) 3.63
Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. JAMA (2007) 3.62
Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria. J Med Genet (2004) 2.95
Involvement of members of the cadherin superfamily in cancer. Cold Spring Harb Perspect Biol (2009) 2.89
Dynamics of adherens junctions in epithelial establishment, maintenance, and remodeling. J Cell Biol (2011) 2.67
Intercellular junction assembly, dynamics, and homeostasis. Cold Spring Harb Perspect Biol (2010) 1.96
Integrins and cadherins join forces to form adhesive networks. J Cell Sci (2011) 1.82
Type I gamma phosphatidylinositol phosphate kinase modulates adherens junction and E-cadherin trafficking via a direct interaction with mu 1B adaptin. J Cell Biol (2007) 1.78
Epithelial E- and P-cadherins: role and clinical significance in cancer. Biochim Biophys Acta (2012) 1.64
Epithelial cell polarity: a major gatekeeper against cancer? Cell Death Differ (2011) 1.51
Characterization of a recurrent germ line mutation of the E-cadherin gene: implications for genetic testing and clinical management. Clin Cancer Res (2005) 1.46
Identification of CDH1 germline missense mutations associated with functional inactivation of the E-cadherin protein in young gastric cancer probands. Hum Mol Genet (2003) 1.42
Germline mutations of the E-cadherin(CDH1) and TP53 genes, rather than of RUNX3 and HPP1, contribute to genetic predisposition in German gastric cancer patients. J Med Genet (2004) 1.38
Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers. J Med Genet (2015) 1.36
{alpha}-Catenin mediates initial E-cadherin-dependent cell-cell recognition and subsequent bond strengthening. Proc Natl Acad Sci U S A (2008) 1.31
Quantitative in vivo imaging of the effects of inhibiting integrin signaling via Src and FAK on cancer cell movement: effects on E-cadherin dynamics. Cancer Res (2010) 1.12
The intracellular E-cadherin germline mutation V832 M lacks the ability to mediate cell-cell adhesion and to suppress invasion. Oncogene (2003) 1.08
E-cadherin germline missense mutations and cell phenotype: evidence for the independence of cell invasion on the motile capabilities of the cells. Hum Mol Genet (2003) 1.02
Familial gastric cancer: genetic susceptibility, pathology, and implications for management. Lancet Oncol (2015) 0.99
EGFR regulates RhoA-GTP dependent cell motility in E-cadherin mutant cells. Hum Mol Genet (2007) 0.98
E-cadherin dysfunction in gastric cancer--cellular consequences, clinical applications and open questions. FEBS Lett (2012) 0.98
Endoplasmic reticulum quality control: a new mechanism of E-cadherin regulation and its implication in cancer. Hum Mol Genet (2008) 0.96
Quantitative cell dispersion analysis: new test to measure tumor cell aggressiveness. Int J Cancer (2001) 0.92
E-cadherin destabilization accounts for the pathogenicity of missense mutations in hereditary diffuse gastric cancer. PLoS One (2012) 0.91
The importance of E-cadherin binding partners to evaluate the pathogenicity of E-cadherin missense mutations associated to HDGC. Eur J Hum Genet (2012) 0.87
E-cadherin alterations in hereditary disorders with emphasis on hereditary diffuse gastric cancer. Prog Mol Biol Transl Sci (2013) 0.87
Cell aggregation assays. Methods Mol Med (2001) 0.86
E-cadherin germline mutation carriers: clinical management and genetic implications. Cancer Metastasis Rev (2014) 0.84
Quantification of mutant E-cadherin using bioimaging analysis of in situ fluorescence microscopy. A new approach to CDH1 missense variants. Eur J Hum Genet (2014) 0.81
Quantitative methods for analyzing cell-cell adhesion in development. Dev Biol (2014) 0.80
The germline CDH1 c.48 G>C substitution contributes to cancer predisposition through generation of a pro-invasive mutation. Mutat Res (2014) 0.80
Convex total variation denoising of Poisson fluorescence confocal images with anisotropic filtering. IEEE Trans Image Process (2010) 0.78